Skip to main content

Physician Toolkit: Management of myelomeningocele

Physician Toolkit: Management of myelomeningocele

Myelomeningocele Experience at CHOP

More than 3,049
Patients referred to the CFDT for suspected Myelomeningocele (MMC)

More than 1,721
Patients evaluated for suspected MMC

473
Fetal surgeries for MMC

620
Babies with MMC delivered in our Special Delivery Unit since 2008

All numbers except deliveries reflect data from 1995-October 2024 at Children's Hospital of Philadelphia.

Prenatal surgery to treat myelomeningocele (MMC), the most severe form of spina bifida, is one of the most exciting developments in the history of treatment for birth defects. It is also an extremely complex procedure that requires extensive experience to perform successfully. Mothers who choose fetal surgery require the most expert and carefully coordinated care from the time of diagnosis, for the spina bifida surgery itself, and through the baby's delivery and care afterwards.

A quick look at our patient volumes and fetal MMC repair outcomes proves the Center is a valued resource for evaluation and treatment of myelomeningocele. Members of our team were not only pioneers in fetal surgery, they developed the prenatal spina bifida surgery procedure and have the greatest collective experience in the world.

Specialists at the Center partner with you to provide a seamless continuum of care, discuss the diagnosis and treatment options, offer suggestions for follow-up if fetal surgery is required, and remain available for consultation for the remainder of the pregnancy as part of the patient's ongoing prenatal management team.

We welcome your questions, comments and referrals.

Resources for professionals

To better partner with you, the Center has created a number of professional-focused resources about myelomeningocele and spina bifida, treatment options before and after birth, as well as offer you resources you can share with your patients.

Referral guidelines for myelomeningocele

Comprehensive individual evaluation of each pregnancy is essential to determine whether fetal surgery for myelomeningocele is appropriate. To help you gain a clearer understanding about when prenatal surgery may be appropriate and when it is not recommended for the health of mother and/or fetus, we have developed referral guidelines for fetal surgery for myelomeningocele.

If you'd like to refer a patient to the Center for Fetal Diagnosis and Treatment for a full evaluation or discuss a case with a member of our team, please contact us at 1-800-IN-UTERO (1-800-468-8376). 

Flip chart: A guide to specialized fetal MMC surgical repair

MMC thumbnail

This flip chart for healthcare professionals provides an overview of spina bifida, facts about myelomeningocele, guidelines for when fetal surgery is a treatment option, and details about the actual prenatal repair, along with recovery time, delivery and follow up care.

You can contact us to request copies of this resource for use in your office, or download the flip chart.

Research

N. Scott Adzick, MD, director of the Center for Fetal Diagnosis and Treatment at CHOP, was lead author on the landmark Management of Myelomeningocele Study (MOMS), which proved the efficacy of prenatal spina bifida repair versus postnatal repair. "A Randomized Trial of Prenatal verses Postnatal Repair of Myelomeningocele" (reported in the New England Journal of Medicine), chronicles the study conducted from 2003 to 2010 at CHOP and two other centers, and establishes fetal surgery for spina bifida as a new standard of care.

The study found prenatal repair resulted in:

  • Reversal of the hindbrain herniation component of the Chiari II malformation
  • Reduced need for ventricular shunting to relieve hydrocephalus
  • Reduced incidence or severity of potentially devastating neurologic effects

The long-awaited results validated the work pioneered by the Center team over more than 20 years; developing the prenatal repair technique, conducting extensive tests in animal models and then cautiously applying the therapy in select patients.

The MOMS trial continues to monitor the original participating families. This unique opportunity to continue to directly compare the long-term effects of prenatal versus postnatal repair will answer many questions about spina bifida, ultimately helping both clinicians and patients make an informed choice about the treatment options available.

A decade later, follow ups to the landmark 2011 study add to a growing body of research affirming the benefits of fetal surgery for spina bifida:

More details about the MOMS trial »

Publications

Staff of the Center for Fetal Diagnosis and Treatment have written extensively about fetal surgery for spina bifida and have established a long legacy of research about myelomeningocele. Visit our publications page for an extensive list of fetal surgery for spina bifida publications »

In Utero Insights newsletter

The myelomeningocele-focused edition of In Utero Insights, the Center's newsletter to the professional community, focused on the landmark MOMS trial that found prenatal repair of myelomeningocele can substantially improve outcomes. This newsletter is also available in Spanish (en Español)

Case study

A 27-year-old woman was referred for assessment of a 23-week gestation fetus with thoracolumbosacral spina bifida. The lesion was first detected on a 20-week ultrasound performed because of an elevated maternal serum alpha-fetoprotein level.

Read this case study about successful fetal surgery for spina bifida repair.

Resources you can share with patients 

Condition content

The Center has detailed, diagnosis-specific information about spina bifida and prenatal repair of spina bifida, as well as other fetal anomalies, written for families.

Fast facts: What you need to know about prenatal spina bifida repair

Fetal repair of myelomeningocele is offered as a standard of care at Children’s Hospital of Philadelphia.

Educational videos

In this video, center team members explain the prenatal myelomeningocele repair procedure and the comprehensive, multidisciplinary care provided for both mother and baby at Children's Hospital of Philadelphia. Created for clinicians and patients, it's essential information about this important treatment option.

This video offers an illustrated explanation of fetal surgery for spina bifida.

  • Spina Bifida Surgery Before Birth: Illustrated Video

    Narrator: Fetal surgery for spina bifida is an incredibly complex procedure. At Children's Hospital of Philadelphia, where the surgery was developed, a team of more than 20 people are in the operating room. They include up to four fetal surgeons, one neurosurgeon, two anesthesiologists, a maternal fetal medicine specialist, a fetal cardiologist and specialized nurses. They have performed this procedure more than any team in the world. Before surgery, the mother receives deep general anesthesia. Fetal surgeons make an incision across the mother’s abdomen. The maternal fetal medicine specialist uses ultrasound to determine the position of the fetus and the margins of the placenta.

    The uterus is then opened with a specially designed uterine stapling device that controls bleeding, and the fetus is positioned so the spinal defect is visible. The fetal cardiologist monitors the baby's heart as the team closes the defect. The neurosurgeon removes a sac on the baby's back that covers the opening in the spinal cord. The sac is a thin membrane filled with fluid. The neurosurgeon and the fetal surgeon then close the defect in multiple layers using a lacing technique.

    First the muscle layers are closed over the defect. Then the skin is closed over the muscle layers. This ensures a watertight closure. The mother's uterus is closed in multiple layers, then her abdomen is closed and she is returned to her room.

    The pregnancy then continues until planned delivery at 37 weeks’ gestation, most often in our Special Delivery Unit created for moms carrying babies with birth defects.

Transcript Transcript
Jump back to top